Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Deal value increased by 320 per cent in September 2025, compared to September 2024
Three major deals contributed 79.7 per cent of the total deal value during September 2025
Lupin launches strategic partnership program to expand reach of its long-acting injectable platform
Following U.S. FDA approval for the first product using PrecisionSphere, Lupin’s new initiative aims to collaborate with global…
Gerresheimer adjusts 2025 financial guidance following slower market growth
Company reports lower-than-expected revenue and EBITDA margin for the first nine months of 2025 and launches a transformation…
Asahi Kasei expands healthcare materials portfolio with launch of two new Sonanos™ excipients
Company introduces Sonanos™ PG and Sonanos™ DS to support formulation challenges in injectable drugs, with GMP-compliant products…
ISHRAE Mumbai Chapter to host pharma connect 2025 on October 10
Pharma Connect 2025 will focus on the theme “Breathing Life into Pharma: Mastering Air Conditioning for a Transformative Future”,…
Owner of Sresan Pharma arrested after 17 children die from toxic cough syrup
Authorities link the deaths of children in Madhya Pradesh to Sresan Pharma’s ‘Coldrif’ syrup containing diethylene glycol
GlobalData reports 320% rise in pharma M&A deal value in September 2025
Pharma industry recorded $20.5 billion in M&A deals and $2.8 billion in venture capital funding during September 2025,…
Sai Life Sciences, Agility Life Sciences and Centrix Pharma Solutions launch integrated CMC…
The collaboration offers end-to-end Chemistry, Manufacturing and Controls (CMC) services to support biopharma innovators from…
Parexel expands site alliance program to accelerate study start-up and patient enrolment
Enhanced program delivers 40% faster site activation, 20% faster study start-up timelines and four times more patient enrolments…
General Atlantic Singapore transfers 3.49 million Rubicon Research shares ahead of IPO
Shares worth Rs 169 crore transferred to mutual funds, while Rubicon Research opens IPO from 9–13 October 2025